James C. Lin

Davis Polk advised the underwriters in the initial public offering and listing on the Hong Kong Stock Exchange and the international offering in reliance on Rule 144A and Regulation S…

Davis Polk advised the underwriters on an SEC-registered offering by Baidu, Inc. of its $600 million 3.075% notes due 2025 and $400 million 3.425% notes due 2030. Baidu, Inc. is a…

Davis Polk advised the underwriters on the SEC-registered initial public offering by I-Mab of 7,407,400 American depositary shares, each 10 ADSs representing 23 ordinary shares, for total…

Davis Polk advised LIZHI INC. on its SEC-registered initial public offering of 4,100,000 American depositary shares for total proceeds of approximately $45.1 million if the underwriters do…

Davis Polk advised the lead underwriters on the SEC-registered initial public offering by Molecular Data Inc. of 11,500,000 American Depositary Shares sold by Molecular Data, for gross…

Davis Polk is advising Universal Scientific Industrial (Shanghai) Co., Ltd. on its acquisition of Asteelflash. Under the terms of the transaction agreement, USI will acquire 100% of the…

Davis Polk advised Venus Medtech (Hangzhou) Inc. in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on Rule…

Davis Polk advised the initial purchaser in connection with a Rule 144A and Regulation S offering by Sea Limited of $1.15 billion aggregate principal amount of its 1.00% convertible senior…

Davis Polk advised the underwriters on the SEC-registered initial public offering by ECMOHO Limited of 4,375,000 American Depositary Shares for gross proceeds of $43.8 million. Each ADS…

Davis Polk advised 36Kr Holdings Inc. on its SEC-registered initial public offering of 1,380,000 American Depositary Shares for total proceeds of approximately $20 million. Each ADS…